Business Wire

MATW-PROJECT

Share
Ali Banat, Founder of Muslims Around The World, Receives TRT World Citizen Award in Recognition of His Lifetime Contributions to Society

The ‘Muslims Around the World Project’ (MATW-Project), a new-generation non-governmental organization building heritage with global impact, was founded by Ali Banat, who passed away from cancer at a young age. To acknowledge his contribution, TRT World Citizen Awards, an organization that honors people who contribute greatly to society, has granted Ali Banat its Lifetime Achievement Award. Mahmoud Ismail, Ali Banat's friend and the CEO of MATW-Project, received the award at the ceremony in Istanbul on November 25 from TRT World, the international English language broadcaster operated by Turkiye's national broadcaster TRT.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221128005245/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

CEO of MATW-Project Mahmoud Ismail and TRT Director General Prof. Zahid Sobacı (Photo: Business Wire)

Ali Banat was an Arab-Australian businessperson who owned a security and electrical company and died in 2018, following a struggle with cancer. Following his cancer diagnosis in October 2015, Ali Banat donated all his wealth to charity and founded MATW-Project.

Mahmoud Ismail expressed his thoughts about the award, saying, "We lost Ali Banat but his legacy lives on in what he did for the world and for charity. His MATW-Project, based in Australia, carries on its business with a strong presence in many countries worldwide, especially in Africa. We would like to thank TRT World for recognizing the contributions of MATW to the world and granting this award to our founder Ali Banat."

This year, the TRT World Citizen Awards held its award ceremonies for the third time. The ceremony was attended by many international people from different parts of society, such as politics, academia, arts, entertainment, humanitarian aid, and business.

This non-profit organization cherishes Ali Banat's legacy and contributes to positive change worldwide. With its 774,000 supporters on social media, the MATW-Project has built more than 950 water wells in Africa to make up for the water shortage, supported more than 1,000 orphan children and touched the lives of more than 3 million people.

The MATW-Project operates on a 100% donation basis, meaning that every donated amount is given to those in need, and provides humanitarian support in countries such as Bangladesh, Pakistan, Palestine, Yemen, Syria, and Afghanistan. It also provides shelter, access to water, education and guidance services in challenging living conditions.

Explaining that they want to maximize the impact of donations through a sustainable model, Ismail concluded his speech: "At the MATW-Project, we strive to build equitable and fair living conditions compatible with human dignity; inspired by our values of reliability, efficiency, sustainability, impact, and belief. I hope that this Lifetime Achievement Award from TRT World to our Founder Ali Banat will help further raise awareness of the MATW-Project's activities by reaching more people around the globe."

Visit us at https://matwproject.org

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005245/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik13.1.2026 15:01:00 CET | Press release

Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optimization in R&D and Medical Affairs. Prior to joining Blue Matter, she served as Managing Director in R&D, Health, Science, and Wellness at EY. She has a robust background in consulting, which also includes roles at Booz Allen Hamilton, Navitas, WPP, and IBM. She holds a BA and MA from the University of Notre Dame and an MSc in Translational Medicine from the University of Edinburgh. The R&D practice, according to Austraat-Churik, exists to help biopharma companies simplify and accelerate the pathway to market. She adds, “R&D organ

Wasabi Raises $70M in New Equity to Power the Next Era of Data Infrastructure13.1.2026 15:00:00 CET | Press release

At a $1.8 billion valuation, backed by L2 Point and Pure Storage, the company scales AI-first cloud storage to meet the explosive demands of modern data Wasabi Technologies, the Hot Cloud Storage company, today announced a $70 million equity funding round led by L2 Point Management with participation from Pure Storage and existing investors including Fidelity Management & Research Company. The new round values Wasabi at $1.8 billion and brings the company’s total funding to over $600 million. The capital will be used to accelerate Wasabi’s expansion into AI infrastructure, broaden its global footprint, and enhance its product portfolio to meet the growing data demands of enterprises and AI developers worldwide. “We’re ushering in the next generation of cloud storage, powering data-intensive workloads like generative AI and autonomous systems,” said David Friend, co-founder and CEO of Wasabi Technologies. “This funding underscores Wasabi’s strong market position and continued growth as

HumanX Amsterdam Reveals First 100 Speakers, Bringing Global AI Powerhouses to Europe13.1.2026 14:00:00 CET | Press release

Anton Osika (Lovable), May Habib (Writer), Jan Oberhauser (n8n) & Eléonore Crespo (Pigment) headline a diverse lineup spanning AI innovation and enterprise adoption HumanX, the global AI summit for executives and innovators, today unveiled its first 100 speakers and opened registration for HumanX Amsterdam, taking place 22–24 September 2026 at The RAI. Built by the team behind Money20/20, Shoptalk, and HLTH, HumanX Amsterdam brings the proven formula of its #1 U.S. flagship event and ecosystem gathering to Europe. The event convenes over 2,500 senior leaders focused on moving beyond the hype to drive practical, responsible AI implementation across industries. Speakers Leading the Conversation The first 100 speakers include AI company founders such as Anton Osika (Lovable), Jan Oberhauser (n8n), May Habib (Writer), Arvind Jain (Glean), and Jarek Kutylowski (DeepL), alongside executives scaling AI in the enterprise, including Clay Bavor (Sierra), Des Traynor (Intercom), and Eléonore Cres

GARDP and Debiopharm Partner to Advance Development of Novel Gonorrhea Drug13.1.2026 14:00:00 CET | Press release

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue the development of Debio1453, a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae. With 82 million new cases each year, and the continued spread of multidrug-resistant N. gonorrhoeae strains, gonorrhea represents a global health crisis. This new partnership will help ensure that gonorrhea continues to be a treatable disease and will alleviate the risk of the emergence of future resistance, by ensuring that the antibiotic pipeline continues to be replenished. Gonorrhea caused by N. gonorrhoeae is currently in danger of becoming untreatable because of antimicrobial resistance (AMR). Having developed resistance to almost all antibiotics used to treat it, only one last recommended treatment, ceftriaxone, remains effective, and now we are seeing a growing number of cases that are

Wolfspeed Achieves 300mm Silicon Carbide (SiC) Technology Breakthrough13.1.2026 14:00:00 CET | Press release

300mm SiC Technology, Enabling Scalable Platforms for AI Infrastructure, AR/VR, and Advanced Power DevicesAnnouncement highlights:Strategic Technology Milestone – Wolfspeed has produced a single crystal 300mm (12-inch) silicon carbide wafer, representing a major advancement in the evolution of silicon carbide technology and a critical enabler for emerging applications. Technology leadership for Next-Gen Applications – Backed by one of the industry’s largest and most foundational silicon carbide IP portfolios, with over 2,300 issued and pending patents worldwide, Wolfspeed is accelerating the commercialization of 300mm technology to power next-generation platforms including AI infrastructure, augmented reality/virtual reality (AR/VR) and advanced power devices. Strengthening U.S. Semiconductor Leadership & Supply Chain Resilience –The company’s vertically integrated supply chain, from crystal growth to advanced packaging, supports national goals around compound semiconductor independenc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye